About

Executive Management

John Doll was former Commissioner of the United States Patent and Trademark Office (USPTO). Previously, he has served as the Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO.

As Commissioner, he was appointed by the US Secretary of Commerce and served as the Chief Operating Officer for all aspects of the patent related operations, planning and policy with the mission of the properly applying the patent laws and regulations of the United States in the examination of patent applications.

He oversaw a budget of $1.3 billion and a staff of over 7000 employees. He was also responsible for Patent's strategic planning and execution, labor management relations, customer outreach, congressional relations, public advisory committee relations, and patent policy formulation.

Board of Directors

John J. Doll

Owner; Former Commissioner,
United States Patent and Trademark Office (USPTO)

Michael Brennan is the Managing Director of Pearl Street Venture Funds.

He was previously a General Partner at Oxford Bioscience Partners. Prior to that, he was the President and Chief Executive Officer of Gene Logic (NASDAQ: GLGC). During Dr. Brennan's time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion. He raised three rounds of venture capital and led Gene Logic to an IPO in November, 1997 and a large secondary public offering in January 2000.

Dr. Brennan's previous experience includes six years in the biopharmaceutical industry, where he has served as Vice President, Business Development for Boehringer Mannheim Therapeutics. Dr. Brennan received a B.S. in biochemistry, a PhD in neurobiology and MD from the University of Witwatersrand, Johannesburg, South Africa.

Board of Directors

Michael Brennan, MD, PhD

Owner; Managing Director,
Pearl Street Venture Funds